This reciprocal effect has been occurred in various therapeutic contexts [35, 36], for example, overexpression of PRKCQ-AS1 has been found to impede the progression of thyroid cancer while simultaneously improving mitochondrial function [37]. Here, PRKCQ is linked to thyroid gland carcinoma.